First Trust Advisors LP Intellia Therapeutics, Inc. Transaction History

First Trust Advisors LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $1.23 Million - $1.69 Million	51,438 New	51,438 $1.42 Million
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $1.05 Million - $1.52 Million	33,208 New	33,208 $1.05 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $4.15 Million - $8.48 Million	-71,282 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$100.76 - $138.36 $587,027 - $806,085	5,826 Added 8.9%	71,282 $8.43 Million
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $647,951 - $865,338	-4,895 Reduced 6.96%	65,456 $8.78 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $1.52 Million - $4.04 Million	-24,946 Reduced 26.18%	70,351 $11.4 Million
Q1 2021 May 14, 2021	BUY	$46.59 - $83.68 $1.18 Million - $2.12 Million	25,283 Added 36.11%	95,297 $7.65 Million
Q4 2020 Feb 02, 2021	BUY	$18.83 - $63.53 $1.32 Million - $4.45 Million	70,014 New	70,014 $3.81 Million
Q1 2019 May 09, 2019	SELL	$12.79 - $17.62 $861,048 - $1.19 Million	-67,322 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$11.39 - $27.13 $1.06 Million - $2.52 Million	-92,981 Reduced 58.0%	67,322 $919,000
Q3 2018 Oct 25, 2018	BUY	$25.78 - $32.6 $1.44 Million - $1.82 Million	55,798 Added 53.39%	160,303 $4.59 Million
Q2 2018 Aug 02, 2018	BUY	$20.02 - $30.79 $2.09 Million - $3.22 Million	104,505 New	104,505 $2.86 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.